Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P7
Near historical low
vs 2Y Ago
-2.8x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
2025-141.71%
2024-150.86%
202350.85%
2022-10.65%
2021-17.08%
2020-22.72%
2019-37.40%
201854.70%
201723.51%
2016-62.80%